I worked for multinational corporations for 10 years. My career grew from sales to marketing. As a product marketing professional, I have launched 10 products in the last 6 years. However, I can’t stop asking myself, “What else can I do to contribute more to my career? Where is the next step to lead to a meaningful life?” Continue Reading
It isn’t easy running a $100,000-a-year, innovative, premium-performance earbud company while balancing the demands of academics and college activities, but freshman Ben Grosse doesn’t shy away from a challenge. Continue Reading
UConn Innovation Portal– UConn alumnus Tim Myles ’14 Ph.D. (ENG) has taken advantage of several NSF I-Corps programs to help commercialize a non-invasive, clinically accurate device that detects and monitors the status of chronic illnesses through analysis of exhaled breath. Hear about his experience with I-Corps, innovation, and entrepreneurship.
The Bristol Press– Sophomore Abigail King won the gold medal certificate for her idea for an interior design consulting business called “Intuit Interiors,” at the 15th Bristol Eastern High School Business Plan Competition (BPC), held recently at the UConn-Waterbury regional campus.
David Noble, a professor-in-residence in the management department at the School of Business, has been named the director of the new Peter J. Werth Institute for Entrepreneurship and Innovation at UConn. Continue Reading
Our final day in Tel Aviv was bittersweet, as we knew our incredible journey was coming to an end. We started the day meeting at YL Ventures, a venture capital (VC) firm like many in Israel that focused on early-stage investing. I was astounded that while the US was trending towards less early/seed-stage capital and much more later-stage investments, Israel seemed to embrace their unique VC ecosystem.
UConn Today– Immunotherapies are promising in theory, but often not in practice. In fact according to experts, they actually only work 10 percent of the time in the treatment of cancer – at best. Yet, while immunotherapy drugs may only help a minority of patients, those who do respond often do extremely well. As a result, many scientists are working to tap into the treatment’s benefits for a wider group of patients.
Today was our second to last day of this trip. Heading out the hotel door at 8:30, we went to our first destination for the day, Caesarea. This is an ancient Roman and Byzantine city that was designed and created by Harrod.